HealthCare Global Enterprises Ltd

HealthCare Global Enterprises Ltd announced the resignation of Dr. Manish Mattoo as Interim Chief Financial Officer, effective May 25, 2026. This follows the appointment of Mr. Sanjeev Kumar as the new Chief Financial Officer and Key Managerial Personnel, approved by the Board of Directors on May 19, 2026. Dr. Mattoo, who also serves as Executive Director and Chief Executive Officer, relinquished the additional charge upon Mr. Kumar's assumption of office. The company has acknowledged Dr. Mattoo's contributions during his tenure as Interim CFO.

HealthCare Global Enterprises Ltd reported no deviations or variations in the utilization of proceeds from its Rights Issue for the quarter ended March 31, 2026. The funds raised, amounting to ₹424.68 Cr, were allocated as per the Letter of Offer dated February 24, 2026, with no changes in the original objectives. This confirmation complies with SEBI regulations and has been reviewed by the Audit Committee.

HealthCare Global Enterprises Ltd (HCG) has re-appointed Mr. Rajiv Maliwal as a Non-Executive Independent Director for a second term of 5 years, effective from May 25, 2026. Additionally, Mr. Sanjeev Kumar has assumed the role of Chief Financial Officer, leading to Dr. Manish Mattoo ceasing to hold the position of Interim CFO. Mr. Ravi Gothwal has been appointed as AVP – Investor Relations and Mr. Vijay S. Shanbhag has been re-appointed as the Internal Auditor for a further term of 1 year with effect from May 30, 2026.

HealthCare Global Enterprises Ltd's board approved the appointment of Mr. Sanjeev Kumar as CFO and Key Managerial Personnel, effective May 25, 2026. Consequently, Dr. Manish Mattoo will cease to be the Interim CFO. Additionally, Mr. Ravi Gothwal was appointed as AVP – Investor Relations, designated as Senior Management Personnel, effective May 19, 2026. The board also approved the re-appointment of Mr. Vijay S. Shanbhag as the Internal Auditor for another year starting May 30, 2026. Mr. Rajiv Maliwal was re-appointed as Non-Executive Independent Director for a second term of 5 years, effective May 25, 2026.

HealthCare Global Enterprises Ltd's Board approved the appointment of Mr. Ravi Gothwal as AVP- Investor Relations, effective May 19, 2026. He will be classified as a Senior Management Personnel. Additionally, Mr. Vijay S. Shanbhag was re-appointed as the Internal Auditor for another year starting May 30, 2026. Sanjeev Kumar assumed the role of CFO, leading to Dr. Manish Mattoo ceasing to hold the Interim CFO position from May 25, 2026. Rajiv Maliwal was re-appointed as Non-Executive Independent Director for a second term of 5 years, effective May 25, 2026.

HealthCare Global Enterprises Ltd's Board re-appointed Mr. Vijay S. Shanbhag as Internal Auditor under Section 138 of the Companies Act, 2013, for one year starting May 30, 2026. Mr. Ravi Gothwal was appointed AVP – Investor Relations, designated as Senior Management Personnel, effective May 19, 2026. Sanjeev Kumar assumed the role of Chief Financial Officer, leading to Dr. Manish Mattoo ceasing to hold the position of Interim CFO from May 25, 2026.

HealthCare Global Enterprises Ltd (HCG) has approved the divestment of its entire equity shareholding in its wholly-owned subsidiary, BACC Health Care Private Limited, to Inviga Healthcare Fund I and its nominee. The consideration for the sale is ₹37,64,44,788, based on a Share Purchase Agreement (SPA). BACC, engaged in fertility and reproductive healthcare, is not a core business activity for HCG. The transaction, a related party transaction, has been approved by the Audit Committee and the Board, finalized after a competitive process, and is on an arm’s length basis. The divestment aligns with HCG's strategic objectives, allowing reinvestment in high-growth areas and cancer services.

HealthCare Global Enterprises Ltd has announced its audited financial results for the quarter and year ended March 31, 2026. The board meeting, which commenced on May 19, 2026, also approved the re-appointment of Mr. Rajiv Maliwal as a Non-Executive Independent Director for a second term and the appointment of Mr. Sanjeev Kumar as Chief Financial Officer and Mr. Ravi Gothwal as AVP - Investor Relations. Additionally, Mr. Vijay S. Shanbhag was re-appointed as Internal Auditor.

HealthCare Global Enterprises Ltd announced the outcome of its board meeting on May 19, 2026, approving the audited financial results for the quarter and year ended March 31, 2026. The board also approved the re-appointment of Mr. Rajiv Maliwal as a Non-Executive Independent Director, the appointment of Mr. Sanjeev Kumar as CFO, and Mr. Ravi Gothwal as AVP - Investor Relations. Additionally, Mr. Vijay S. Shanbhag was re-appointed as Internal Auditor.

HealthCare Global Enterprises Ltd has launched a new comprehensive cancer hospital in Hebbal, North Bangalore, with a capacity of up to 132 beds. The facility, named 'HCG Cancer Hospital, Hebbal,' aims to enhance access to advanced oncology care in the region. The hospital introduces Karnataka’s first Elekta Unity MR-Linac, an advanced precision radiation therapy platform. The project required an investment of approximately ₹129 Crores, financed through a mix of debt and internal accruals.